Adaptive Biotechnologies Corp vs Tapestry, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Tapestry, Inc. trades at $161 (market cap $32.44B). The key difference: Tapestry, Inc. is far larger — about 8× Adaptive Biotechnologies Corp's market cap, and Tapestry, Inc. pays a 1% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | TPR | |
|---|---|---|
Market Cap | $4.04B | $32.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $164.78 |
52-Week Low | $12.30 | $95.69 |
Enterprise Value | $4.10B | $35.29B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →